
Chinese Government’s Evaluation Process Of Manufacturers’ Standards And Qualifications For Relevant Epidemic Prevention Products
View a flow chart of the evaluation process.
Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.
View a flow chart of the evaluation process.
The Chinese government announced a process to export particular devices without NMPA approval.
Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.
This guidance helps member companies support decision-making and mitigate compliance risks.
This infographic depicts the process of COVID-19 diagnostic tests from patient sample to test results.
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
ABHI and AdvaMed® will coordinate activities.
The VALID Act seeks to modernize FDA oversight of in vitro diagnostics.
The presentation slides include a decision-making framework for preparing to re-open offices.
This short checklist provides links to relevant documents related to DPA and COVID-19 and trade in medical devices.